Treatment of Severe Hailey-Hailey Disease With Apremilast | Zendy

Julie Kieffer | Zendy; F. Le Duff | Zendy; H. Montaudié | Zendy; C. Chiavérini | Zendy; J.P. Lacour | Zendy; Thierry Passeron | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment of Severe Hailey-Hailey Disease With Apremilast

Author(s) -

Julie Kieffer,

F. Le Duff,

H. Montaudié,

C. Chiavérini,

J.P. Lacour,

Thierry Passeron

Publication year - 2018

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2018.2191

Subject(s) - medicine , apremilast , hailey–hailey disease , dermatology , nice , outpatient clinic , adverse effect , infliximab , disease , surgery , psoriasis , psoriatic arthritis , computer science , programming language

Hailey-Hailey disease (HHD) is a rare, autosomal-dominant acantholytic dermatosis characterized clinically by development of recurrent blisters and erosions in friction areas. Despite progression in our understanding of the molecular genetics of HHD, therapy remains suboptimal and there is no known cure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research